David Eansor

2021

In 2021, David Eansor earned a total compensation of $6.4M as Former President, Protein Sciences at Bio-Techne, a 140% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,005,360
Option Awards$4,379,953
Salary$585,000
Stock Awards$459,844
Other$8,372
Total$6,438,528

Eansor received $4.4M in option awards, accounting for 68% of the total pay in 2021.

Eansor also received $1M in non-equity incentive plan, $585K in salary, $459.8K in stock awards and $8.4K in other compensation.

Rankings

In 2021, David Eansor's compensation ranked 1,969th out of 12,415 executives tracked by ExecPay. In other words, Eansor earned more than 84.1% of executives.

ClassificationRankingPercentile
All
1,969
out of 12,415
84th
Division
Manufacturing
745
out of 5,505
87th
Major group
Chemicals And Allied Products
288
out of 2,375
88th
Industry group
Drugs
247
out of 2,096
88th
Industry
Biological Products, Except Diagnostic Substances
75
out of 449
83rd
Source: SEC filing on September 14, 2022.

Eansor's colleagues

We found four more compensation records of executives who worked with David Eansor at Bio-Techne in 2021.

2021

Charles Kummeth

Bio-Techne

Chief Executive Officer

2021

James Hippel

Bio-Techne

Chief Financial Officer

2021

Brenda Furlow

Bio-Techne

General Counsel

2021

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

News

In-depth

You may also like